Literature DB >> 21751351

Proteomic analysis reveals perturbed energy metabolism and elevated oxidative stress in hearts of rats with inborn low aerobic capacity.

Jatin G Burniston1, Jenna Kenyani, Jonathan M Wastling, Charles F Burant, Nathan R Qi, Lauren G Koch, Steven L Britton.   

Abstract

Selection on running capacity has created rat phenotypes of high-capacity runners (HCRs) that have enhanced cardiac function and low-capacity runners (LCRs) that exhibit risk factors of metabolic syndrome. We analysed hearts of HCRs and LCRs from generation 22 of selection using DIGE and identified proteins from MS database searches. The running capacity of HCRs was six-fold greater than LCRs. DIGE resolved 957 spots and proteins were unambiguously identified in 369 spots. Protein expression profiling detected 67 statistically significant (p<0.05; false discovery rate <10%, calculated using q-values) differences between HCRs and LCRs. Hearts of HCR rats exhibited robust increases in the abundance of each enzyme of the β-oxidation pathway. In contrast, LCR hearts were characterised by the modulation of enzymes associated with ketone body or amino acid metabolism. LCRs also exhibited enhanced expression of antioxidant enzymes such as catalase and greater phosphorylation of α B-crystallin at serine 59, which is a common point of convergence in cardiac stress signalling. Thus, proteomic analysis revealed selection on low running capacity is associated with perturbations in cardiac energy metabolism and provided the first evidence that the LCR cardiac proteome is exposed to greater oxidative stress.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21751351      PMCID: PMC3319703          DOI: 10.1002/pmic.201000593

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  41 in total

1.  Cell signaling pathways to alphaB-crystallin following stresses of the cytoskeleton.

Authors:  Nathalie Launay; Bertrand Goudeau; Kanefusa Kato; Patrick Vicart; Alain Lilienbaum
Journal:  Exp Cell Res       Date:  2006-08-09       Impact factor: 3.905

2.  Epistasis and the release of genetic variation during long-term selection.

Authors:  Orjan Carlborg; Lina Jacobsson; Per Ahgren; Paul Siegel; Leif Andersson
Journal:  Nat Genet       Date:  2006-03-12       Impact factor: 38.330

3.  Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia.

Authors:  Saul R Powell; Samson Mathews Samuel; Ping Wang; Andras Divald; Mahesh Thirunavukkarasu; Srikanth Koneru; Xuejun Wang; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2008-01-26       Impact factor: 5.000

Review 4.  The PPAR regulatory system in cardiac physiology and disease.

Authors:  Brian N Finck
Journal:  Cardiovasc Res       Date:  2006-09-01       Impact factor: 10.787

5.  Lower oxidative DNA damage despite greater ROS production in muscles from rats selectively bred for high running capacity.

Authors:  Constance Tweedie; Caroline Romestaing; Yan Burelle; Adeel Safdar; Mark A Tarnopolsky; Scott Seadon; Steven L Britton; Lauren G Koch; Russell T Hepple
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-09       Impact factor: 3.619

Review 6.  Palmitoylcarnitine, a surface-active metabolite.

Authors:  F M Goñi; M A Requero; A Alonso
Journal:  FEBS Lett       Date:  1996-07-15       Impact factor: 4.124

7.  Adaptation of the rat cardiac proteome in response to intensity-controlled endurance exercise.

Authors:  Jatin G Burniston
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

8.  Reduced expression of GSTM2 and increased oxidative stress in spontaneously hypertensive rat.

Authors:  Si-Gui Zhou; Ping Wang; Rong-Biao Pi; Jie Gao; Jia-Jia Fu; Jian Fang; Jia Qin; Hui-Jie Zhang; Rui-Fang Li; Shao-Rui Chen; Fu-Tian Tang; Pei-Qing Liu
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

9.  Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.

Authors:  Heiko Bugger; Michael Schwarzer; Dong Chen; Andrea Schrepper; Paulo A Amorim; Maria Schoepe; T Dung Nguyen; Friedrich W Mohr; Oleh Khalimonchuk; Bart C Weimer; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2009-10-19       Impact factor: 10.787

10.  Kinetics of the translocation and phosphorylation of alphaB-crystallin in mouse heart mitochondria during ex vivo ischemia.

Authors:  R Whittaker; M S Glassy; N Gude; M A Sussman; R A Gottlieb; C C Glembotski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

View more
  14 in total

1.  Circadian modulation of the cardiac proteome underpins differential adaptation to morning and evening exercise training: an LC-MS/MS analysis.

Authors:  Dae Yun Seo; Chang Shin Yoon; Louise Anne Dizon; Sung Ryul Lee; Jae Boum Youm; Won Suk Yang; Hyo-Bum Kwak; Tae Hee Ko; Hyoung Kyu Kim; Jin Han; Robin A McGregor
Journal:  Pflugers Arch       Date:  2020-02-06       Impact factor: 3.657

2.  Label-free profiling of white adipose tissue of rats exhibiting high or low levels of intrinsic exercise capacity.

Authors:  Kelly Bowden-Davies; Joanne Connolly; Paul Burghardt; Lauren G Koch; Steven L Britton; Jatin G Burniston
Journal:  Proteomics       Date:  2015-05-12       Impact factor: 3.984

3.  Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation.

Authors:  Katherine A Overmyer; Charles R Evans; Nathan R Qi; Catherine E Minogue; Joshua J Carson; Christopher J Chermside-Scabbo; Lauren G Koch; Steven L Britton; David J Pagliarini; Joshua J Coon; Charles F Burant
Journal:  Cell Metab       Date:  2015-03-03       Impact factor: 27.287

4.  Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function.

Authors:  Rebecca H Ritchie; Chen Huei Leo; Chengxue Qin; Erin J Stephenson; Marissa A Bowden; Keith D Buxton; Sarah J Lessard; Donato A Rivas; Lauren G Koch; Steven L Britton; John A Hawley; Owen L Woodman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-21       Impact factor: 4.733

5.  Striated muscle-specific serine/threonine-protein kinase beta segregates with high versus low responsiveness to endurance exercise training.

Authors:  Denis Kusić; Joanne Connolly; Heikki Kainulainen; Ekaterina A Semenova; Oleg V Borisov; Andrey K Larin; Daniil V Popov; Edward V Generozov; Ildus I Ahmetov; Steven L Britton; Lauren G Koch; Jatin G Burniston
Journal:  Physiol Genomics       Date:  2019-12-02       Impact factor: 3.107

6.  Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity.

Authors:  Virginia L Johnsen; Darrell D Belke; Curtis C Hughey; Dustin S Hittel; Russell T Hepple; Lauren G Koch; Steven L Britton; Jane Shearer
Journal:  Physiol Genomics       Date:  2012-11-06       Impact factor: 3.107

7.  Brain activation patterns at exhaustion in rats that differ in inherent exercise capacity.

Authors:  Teresa E Foley; Leah R Brooks; Lori J Gilligan; Paul R Burghardt; Lauren G Koch; Steven L Britton; Monika Fleshner
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 8.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

9.  Label-Free LC-MS Profiling of Skeletal Muscle Reveals Heart-Type Fatty Acid Binding Protein as a Candidate Biomarker of Aerobic Capacity.

Authors:  Zulezwan Ab Malik; James N Cobley; James P Morton; Graeme L Close; Ben J Edwards; Lauren G Koch; Steven L Britton; Jatin G Burniston
Journal:  Proteomes       Date:  2013-12-01

Review 10.  Effects of hypertension and exercise on cardiac proteome remodelling.

Authors:  Bernardo A Petriz; Octavio L Franco
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.